QCM
EW icon

QRG Capital Management’s Edwards Lifesciences EW Stock Holding History

QRG Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.33M Buy
69,999
+9,672
+16% +$810K 0.05% 273
2026
Q1 		$4.83M Buy
60,327
+5,863
+11% +$483K 0.05% 280
2025
Q4 		$4.64M Buy
54,464
+18,172
+50% +$1.49M 0.05% 264
2025
Q3 		$2.82M Sell
36,292
-3,946
-10% -$308K 0.03% 325
2025
Q2 		$3.15M Sell
40,238
-43,056
-52% -$3.21M 0.03% 392
2025
Q1 		$6.04M Buy
83,294
+5,992
+8% +$429K 0.06% 268
2024
Q4 		$5.72M Buy
77,302
+57
+0.1% +$3.99K 0.06% 269
2024
Q3 		$5.1M Buy
77,245
+30,892
+67% +$2.24M 0.06% 283
2024
Q2 		$4.28M Buy
46,353
+1,898
+4% +$168K 0.05% 291
2024
Q1 		$4.25M Sell
44,455
-5,189
-10% -$436K 0.05% 290
2023
Q4 		$3.79M Buy
49,644
+2,939
+6% +$204K 0.06% 304
2023
Q3 		$3.24M Buy
+46,705
New +$3.75M 0.06% 300

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

QRG Capital Management's EW Position: Q2 2026 in Review

QRG Capital Management increased its Edwards Lifesciences (EW) stake by 16% in Q2 2026, buying an estimated $810K and bringing the position to 69,999 shares worth $6.33M. The position accounts for 0.05% of the portfolio, ranked #273.

QRG Capital Management first reported a position in EW in Q3 2023 and has held it in 12 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • QRG Capital Management held 69,999 shares of Edwards Lifesciences worth $6.33M as of Q2 2026.
  • QRG Capital Management bought 9,672 Edwards Lifesciences shares in Q2 2026, an estimated $810K.
  • Edwards Lifesciences made up 0.05% of QRG Capital Management's portfolio in Q2 2026, its #273 holding.
  • QRG Capital Management first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 12 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.